Saint Louis University Liver Center scientists are presenting research today on a more effective way to treat hepatitis C patients who have been unresponsive to current// drug therapies.
They have shown that a cocktail of ribavirin and Infergen, a highly potent Interferon, is nearly twice as effective at controlling hepatitis C than standard treatments. They are sharing their findings at the annual American Association for the Study of Liver Diseases meeting in Boston.
“The results are promising,” says Bruce R. Bacon, M.D., principal investigator and director of the division of gastroenterology and hepatology at Saint Louis University School of Medicine. “This group of non-responders is a very challenging population to treat, and we found that patients who followed through with the therapy had a response nearly twice that of previous trials looking at this population.”
Saint Louis University Liver Center researchers led a study of more than 500 patients with hepatitis C at 40 sites, 77 percent of whom had advanced fibrosis. Fourteen percent of patients taking 9mcg of Infergen daily and 20 percent taking 15 mcg were virus negative after six months.
A quarter of the non-cirrhotic patients receiving Infergen were also virus negative after 24 weeks. The optimal response to antiviral therapy is for the hepatitis C viral RNA to become undetectable on treatment and to remain undetectable for at least another six months off therapy; this is referred to as a sustained virologic response, essentially a cure of the disease. Rates of sustained virologic response are still to be determined in this ongoing study.
Infergen is a highly potent type of interferon currently used for adult patients with chronic hepatitis C three times a week, Bacon says. This trial is expected to be completed in 2007.
An estimated 3.9 million Americans have hepatitis C. About 250,000 who have been offered therapy are unresponsivePage: 1 2 Related medicine news :1
. Hyderabad To Have Asia’s First Catheter Making Uni2
. Making Fortification Mandatory In Order To Reduce Birth Defects 3
. Making operation and recovery time shorter 4
. Making MRIs Safe for Patients With Implantable Heart Devices5
. Novel Study Unravels a New Dimension to Decision Making6
. Distinct Brain Sections Are Activated While Making Risky Decisions7
. Sexy Images and Lingerie Challenge A Man’s Decision Making Skill8
. Decision-Making Enabled By Neurons: Value Assigned To Available Choices.9
. Making Budhia run 65 km absolutely cruel,says Infosys chief10
. Making a mocktail of chemical cocktail in children’s blood11
. Antihistamine Proved Ineffective in Making Kids to Sleep